By this measure, there is probably not a single large company board that is not evaluating substantial investments in digital transformation, as all manner of emerging technologies are bandied about by executives and their hired consultants as the panacea of years of structural ossification and competitive pressure.
Here we discuss how the issue of equivalence has been dealt with in the area of clinical medicine, and suggest an analogous approach for evaluating substantial equivalence for transgenic crops.
The composition of samples collected from transgenic varieties can be compared with intervals constructed from the values tabulated in the ILSI crop-composition database and from these concurrently grown reference lines to evaluate substantial equivalence.
Specifically, we suggest how reference intervals should be calculated for evaluating the substantial equivalence of new transgenic crops relative to existing crop varieties that have a history of safe use.
Although this approach has been suggested for evaluating the substantial equivalence of transgenic crops [ 29, 30], the aforementioned pharmaceutical situation is fundamentally different from that of transgenic-crop composition comparisons.
Therefore, we analysed the Internet by evaluating a substantial number of breast cancer web sites in English and German language, representing the most and second-most frequent language (52.0 and 7.0%, respectively) used on the Internet (Pimienta et al, 2001).
Thus, the use of metabolomic techniques as well as other omics tools to survey the wide range of metabolites is important to evaluate the substantial equivalence of GM crops [7, 12, 19].
Using 20 breast tumor samples and adjusted analytical methods, we observed high overall concordance between the three platforms evaluated, despite substantial differences in the platform composition.
Here we present these tolerance intervals for corn, cotton, and soybean, and discuss the merits of using these intervals to evaluate the substantial equivalence of transgenic crops compared with conventional crop varieties.
Making use of comparative analyses of fruit quality, tree morphology and phenology conducted over several years, the present work evaluates the substantial equivalence of field-grown transgenic citrus plants relative to their non-GM counterparts.
PET/CT, mostly performed with contrast-enhancement, were independently evaluated with substantial agreement by two readers blinded to any clinical, laboratory or pathology data accumulated after the date of PET/CT.
